Skip to main content
ArticleOPEN ACCESS

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations

Therapeutics and Clinical Risk Management
DOI: 10.2147/TCRM.S54607
7Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Zhao, X. Y., Xu, H. M., & Zhou, Q. (2013). Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/TCRM.S54607

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free